HBK Investments’s AMAG Pharmaceuticals AMAG Stock Holding History

HBK Investments’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-26,200	Closed	-$398K	–	1466
2018 Q4	$398K	Sell	26,200 -35,300	-57%	-$673K	﹤0.01%	956
2018 Q3	$1.23M	Buy	61,500 +28,100	+84%	+$640K	0.01%	663
2018 Q2	$651K	Buy	33,400 +3,819	+13%	+$84.5K	﹤0.01%	736
2018 Q1	$596K	Buy	+29,581	New	+$500K	﹤0.01%	741
2016 Q1	–	Sell	-13,600	Closed	-$411K	–	1171
2015 Q4	$411K	Buy	+13,600	New	+$439K	﹤0.01%	795
2015 Q3	–	Sell	-29,100	Closed	-$2.01M	–	1175
2015 Q2	$2.01M	Buy	+29,100	New	+$1.83M	0.02%	410
2015 Q1	–	Sell	-42,498	Closed	-$1.81M	–	1217
2014 Q4	$1.81M	Buy	+42,498	New	+$1.54M	0.02%	413
2014 Q1	–	Sell	-25,600	Closed	-$621K	–	1092
2013 Q4	$621K	Buy	+25,600	New	+$602K	0.01%	595

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HBK Investments's AMAG Position: Q1 2019 in Review

HBK Investments sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 26,200 shares — an estimated $398K sold.

HBK Investments first reported a position in AMAG in Q4 2013 and held it in 8 quarters. The position peaked at $2.01M in Q2 2015. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

HBK Investments reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
HBK Investments sold 26,200 AMAG Pharmaceuticals shares in Q1 2019, an estimated $398K.
HBK Investments first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 8 quarters.
HBK Investments's AMAG Pharmaceuticals position peaked at $2.01M in Q2 2015.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.